Cargando…

Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials

Long-term diabetes increases the likelihood of developing secondary damage to numerous systems, and these complications represent a substantial cause of morbidity and mortality. Establishing the causes of diabetes remains the key step towards eradicating the disease, but the prevention and ameliorat...

Descripción completa

Detalles Bibliográficos
Autores principales: Calcutt, Nigel A., Cooper, Mark E., Kern, Tim S., Schmidt, Ann Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097138/
https://www.ncbi.nlm.nih.gov/pubmed/19404313
http://dx.doi.org/10.1038/nrd2476
_version_ 1783510957866090496
author Calcutt, Nigel A.
Cooper, Mark E.
Kern, Tim S.
Schmidt, Ann Marie
author_facet Calcutt, Nigel A.
Cooper, Mark E.
Kern, Tim S.
Schmidt, Ann Marie
author_sort Calcutt, Nigel A.
collection PubMed
description Long-term diabetes increases the likelihood of developing secondary damage to numerous systems, and these complications represent a substantial cause of morbidity and mortality. Establishing the causes of diabetes remains the key step towards eradicating the disease, but the prevention and amelioration of diabetic complications is equally important for the millions of individuals who already have the disease or are likely to develop it before prophylaxis or a cure become routinely available. In this Review, we focus on four common complications of diabetes, discuss the range of pathologies that are precipitated by hyperglycaemia and highlight emerging targets for therapeutic intervention.
format Online
Article
Text
id pubmed-7097138
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70971382020-03-26 Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials Calcutt, Nigel A. Cooper, Mark E. Kern, Tim S. Schmidt, Ann Marie Nat Rev Drug Discov Article Long-term diabetes increases the likelihood of developing secondary damage to numerous systems, and these complications represent a substantial cause of morbidity and mortality. Establishing the causes of diabetes remains the key step towards eradicating the disease, but the prevention and amelioration of diabetic complications is equally important for the millions of individuals who already have the disease or are likely to develop it before prophylaxis or a cure become routinely available. In this Review, we focus on four common complications of diabetes, discuss the range of pathologies that are precipitated by hyperglycaemia and highlight emerging targets for therapeutic intervention. Nature Publishing Group UK 2009 /pmc/articles/PMC7097138/ /pubmed/19404313 http://dx.doi.org/10.1038/nrd2476 Text en © Nature Publishing Group 2009 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Calcutt, Nigel A.
Cooper, Mark E.
Kern, Tim S.
Schmidt, Ann Marie
Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials
title Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials
title_full Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials
title_fullStr Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials
title_full_unstemmed Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials
title_short Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials
title_sort therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097138/
https://www.ncbi.nlm.nih.gov/pubmed/19404313
http://dx.doi.org/10.1038/nrd2476
work_keys_str_mv AT calcuttnigela therapiesforhyperglycaemiainduceddiabeticcomplicationsfromanimalmodelstoclinicaltrials
AT coopermarke therapiesforhyperglycaemiainduceddiabeticcomplicationsfromanimalmodelstoclinicaltrials
AT kerntims therapiesforhyperglycaemiainduceddiabeticcomplicationsfromanimalmodelstoclinicaltrials
AT schmidtannmarie therapiesforhyperglycaemiainduceddiabeticcomplicationsfromanimalmodelstoclinicaltrials